| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.08 |